Search Results - "Mehta, Rashmi"
-
1
Characterization of True and False Positive Findings on Contrast-Enhanced Mammography
Published in Academic radiology (01-11-2022)“…The purpose of this paper is to characterize true and false positive findings on contrast-enhanced mammography (CEM) and correlate enhancement pattern and…”
Get full text
Journal Article -
2
Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD
Published in Chest (01-05-2014)“…Background Combination long-acting bronchodilator therapy may be more effective than long-acting bronchodilator monotherapy in COPD. Our objectives were to…”
Get full text
Journal Article -
3
Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial
Published in PloS one (17-12-2012)“…Umeclidinium bromide (GSK573719; UMEC), a new long-acting muscarinic receptor antagonist (LAMA), is in development with vilanterol (GW642444; VI), a selective…”
Get full text
Journal Article -
4
Impact of imaging nurse navigation on breast interventions: Direct and closed-loop patient communication and documentation
Published in Clinical imaging (01-09-2023)“…A breast imaging nurse navigator (NN) was established with the goals to enhance the patient experience after biopsy, improve care timeliness, accuracy, and…”
Get full text
Journal Article -
5
Reference evapotranspiration (ETo) and crop water requirement (ETc) of wheat and maize in Gujarat
Published in Journal of agrometeorology (01-06-2015)“…The reference evapotranspiration (ETo) is an important agrometeorological parameter which has been used in a number of applications. In present study daily ETo…”
Get full text
Journal Article -
6
Breast Imaging Fellowship Training in the United States: A National Survey of Fellowship Program Directors
Published in Journal of breast imaging (30-11-2023)“…Abstract Objective To provide an updated characterization of breast imaging fellowship programs in the United States to identify opportunities for improvement…”
Get full text
Journal Article -
7
Contrast-enhanced Mammography: A Guide to Setting Up a New Clinical Program
Published in Journal of breast imaging (21-05-2021)“…Abstract Contrast-enhanced mammography (CEM) is gaining rapid traction following the U.S. Food and Drug Administration approval for diagnostic indications…”
Get full text
Journal Article -
8
Crop water requirement (ETc) of different crops of middle Gujarat
Published in Journal of agrometeorology (01-06-2016)“…Accurate estimation of crop water requirements (ETc) of any crop is essentially required for irrigation scheduling and water management. The present study was…”
Get full text
Journal Article -
9
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1
Published in Infectious diseases and therapy (01-08-2024)“…Introduction Once-daily fixed-dose combinations (FDC) containing abacavir (ABC), dolutegravir (DTG), and lamivudine (3TC) have been approved in the US for…”
Get full text
Journal Article -
10
Pharmacokinetics and tolerability of inhaled umeclidinium and vilanterol alone and in combination in healthy Chinese subjects: a randomized, open-label, crossover trial
Published in PloS one (27-03-2015)“…Inhaled umeclidinium (UMEC) and the combination of inhaled UMEC with vilanterol (UMEC/VI) are approved maintenance treatments for chronic obstructive pulmonary…”
Get full text
Journal Article -
11
A randomized, double-blind, placebo-controlled, parallel-group study of once-daily inhaled fluticasone furoate on the hypothalamic-pituitary-adrenocortical axis of children with asthma
Published in Allergy, asthma, and clinical immunology (04-02-2020)“…To evaluate the effects of fluticasone furoate on the hypothalamic-pituitary-adrenocortical axis, and the safety and tolerability of fluticasone furoate…”
Get full text
Journal Article -
12
Effects of Moderate Hepatic Impairment on the Pharmacokinetic Properties and Tolerability of Umeclidinium and Vilanterol in Inhalational Umeclidinium Monotherapy and Umeclidinium/Vilanterol Combination Therapy: An Open-Label, Nonrandomized Study
Published in Clinical therapeutics (01-07-2014)“…Abstract Background The long-acting muscarinic antagonist umeclidinium (UMEC) is approved as a monotherapy, and in combination with the long-acting β2 -agonist…”
Get full text
Journal Article -
13
Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study
Published in International journal of chronic obstructive pulmonary disease (01-01-2013)“…The combination of umeclidinium (UMEC), a long-acting muscarinic receptor antagonist, and vilanterol (VI), a selective long-acting β₂ agonist, is in…”
Get full text
Journal Article -
14
A technique to prevent overfilling of viewing chamber of intravenous infusion kit
Published in Indian journal of anaesthesia (01-11-2014)“…Inflation of the BP cuff on this limb leads to back flow of fluid/blood through the transfusion tubing leading to complete filling of the viewing chamber of…”
Get full text
Journal Article -
15
Dose-Related Efficacy of GSK573719: A Long-Acting Muscarinic Receptor Antagonist (LAMA) With Sustained 24-Hour Activity in COPD
Published in Chest (23-10-2011)Get full text
Journal Article -
16
Inhaled nitric oxide in managing preterm infants with suspected pulmonary hypoplasia
Published in Acta Paediatrica (01-03-2021)Get full text
Journal Article -
17
Umeclidinium in patients with COPD: a randomised, placebo-controlled study
Published in The European respiratory journal (2014)“…Efficacy and safety of umeclidinium administered in a dry power inhaler were evaluated in moderate-to-very-severe chronic obstructive pulmonary disease…”
Get full text
Journal Article -
18
Linerixibat dose-response analysis of C4 concentrations as a quantitative approach to predict gastrointestinal tolerability
Published in Journal of hepatology (01-07-2022)Get full text
Journal Article -
19
Population Dose–Response‐Time Analysis of Itch Reduction and Patient‐Reported Tolerability Supports Phase III Dose Selection for Linerixibat
Published in Clinical pharmacology and therapeutics (01-02-2024)“…Increase in serum bile acids (BAs) in patients with primary biliary cholangitis (PBC) may play a causal role in cholestatic pruritus (itch). Linerixibat is a…”
Get full text
Journal Article -
20
Integrated Population Exposure–Response of Dolutegravir in HIV‐1 Supports Bridging of Clinical Response Influenced by Relevant Intrinsic and Extrinsic Patient Characteristics
Published in Clinical pharmacology and therapeutics (01-10-2024)“…Dolutegravir (DTG) is a human immunodeficiency virus type 1 (HIV‐1) integrase strand transfer inhibitor indicated in combination with other antiretroviral…”
Get full text
Journal Article